Sobi - Swedish Orphan Biovitrum AB (publ) is a global leader in providing innovative treatments for people with rare diseases. Specializing in therapeutic areas such as haematology and immunology, Sobi is committed to improving patient access to medicines for rare and debilitating conditions. With a strong R&D pipeline, the company is actively pursuing new therapies and collaborating globally to transform patient care in areas such as haemophilia and immune thrombocytopenia. Sobi also engages in extensive sustainability and humanitarian aid programs, demonstrating a firm commitment to patient-centric care and societal contributions.
orphan drugs • hereditary metabolic disorders • haemophilia • biopharmaceuticals • patient access
November 27
1001 - 5000
🧬 Biotechnology
💊 Pharmaceuticals
⚕️ Healthcare Insurance
Lead clinical development for Sobi’s innovative therapies in rare diseases. Provide strategic insight and ensure compliance throughout study processes.
November 27
1001 - 5000
🧬 Biotechnology
💊 Pharmaceuticals
⚕️ Healthcare Insurance
Lead Sobi's clinical development activities. Provide expertise in regulatory and drug safety.
November 19
1001 - 5000
🧬 Biotechnology
💊 Pharmaceuticals
⚕️ Healthcare Insurance
Join Sobi to lead sales and marketing projects for Haemophilia brands in the region.
November 10
1001 - 5000
🧬 Biotechnology
💊 Pharmaceuticals
⚕️ Healthcare Insurance
Lead global regulatory strategies for rare disease therapies at Sobi.